BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30545525)

  • 1. The Use of Codeine and Tramadol in the Pediatric Population-What is the Verdict Now?
    Fortenberry M; Crowder J; So TY
    J Pediatr Health Care; 2019 Jan; 33(1):117-123. PubMed ID: 30545525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tramadol: keep calm and carry on.
    Anderson BJ; Thomas J; Ottaway K; Chalkiadis GA
    Paediatr Anaesth; 2017 Aug; 27(8):785-788. PubMed ID: 28685989
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.
    Zahari Z; Ismail R
    Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA warns against use of codeine and tramadol in children and breastfeeding women.
    Med Lett Drugs Ther; 2017 May; 59(1521):86-88. PubMed ID: 28520700
    [No Abstract]   [Full Text] [Related]  

  • 5. Codeine and Tramadol Contraindicated for Pediatric Use.
    Aschenbrenner DS
    Am J Nurs; 2017 Aug; 117(8):23. PubMed ID: 28749880
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.
    Stamer UM; Stüber F; Muders T; Musshoff F
    Anesth Analg; 2008 Sep; 107(3):926-9. PubMed ID: 18713907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tramadol, breast feeding and safety in the newborn.
    Palmer GM; Anderson BJ; Linscott DK; Paech MJ; Allegaert K
    Arch Dis Child; 2018 Dec; 103(12):1110-1113. PubMed ID: 29599166
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
    Crews KR; Gaedigk A; Dunnenberger HM; Leeder JS; Klein TE; Caudle KE; Haidar CE; Shen DD; Callaghan JT; Sadhasivam S; Prows CA; Kharasch ED; Skaar TC;
    Clin Pharmacol Ther; 2014 Apr; 95(4):376-82. PubMed ID: 24458010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).
    Matic M; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Mulder H; Rongen GAPJM; Weide JV; Wilffert B; Swen JJ; Guchelaar HJ; Deneer VHM; van Schaik RHN
    Eur J Hum Genet; 2022 Oct; 30(10):1105-1113. PubMed ID: 34267337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tramadol: respiratory depression in a child.
    Prescrire Int; 2016 Feb; 25(168):44. PubMed ID: 27073815
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.
    Crews KR; Gaedigk A; Dunnenberger HM; Klein TE; Shen DD; Callaghan JT; Kharasch ED; Skaar TC;
    Clin Pharmacol Ther; 2012 Feb; 91(2):321-6. PubMed ID: 22205192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codeine: Time to Say "No".
    Tobias JD; Green TP; Coté CJ; ;
    Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27647717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codeine Ultra-rapid Metabolizers: Age Appears to be a Key Factor in Adverse Effects of Codeine.
    Heintze K; Fuchs W
    Drug Res (Stuttg); 2015 Dec; 65(12):640-4. PubMed ID: 25585351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol.
    Orliaguet G; Hamza J; Couloigner V; Denoyelle F; Loriot MA; Broly F; Garabedian EN
    Pediatrics; 2015 Mar; 135(3):e753-5. PubMed ID: 25647677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.
    Knisely MR; Carpenter JS; Draucker CB; Skaar T; Broome ME; Holmes AM; Von Ah D
    Appl Nurs Res; 2017 Dec; 38():107-110. PubMed ID: 29241501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2D6-inhibiting drugs and the increased risk of fall-related injuries due to newly initiated opioid treatment--a Swedish, register-based case-crossover study.
    Möller J; Laflamme L; Söderberg Löfdal K
    Basic Clin Pharmacol Toxicol; 2015 Feb; 116(2):134-9. PubMed ID: 24975450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of Codeine and Tramadol in Children.
    Jin J
    JAMA; 2017 Oct; 318(15):1514. PubMed ID: 29049655
    [No Abstract]   [Full Text] [Related]  

  • 19. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.
    Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problem forte--is paracetamol-codeine combination rational?].
    Helland A; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2084-7. PubMed ID: 15334119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.